Caregiver burden by severity of patient’s heart failure due to transthyretin amyloid cardiomyopathy: results from a large, non-interventional, real-world study
Cappelli F, Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy: post hoc analysis of an international survey study
Cappelli F, Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Burden of transthyretin amyloid cardiomyopathy in treatment-naïve patients by heart failure severity: results from a large, non-interventional, real-world study
Cappelli F, Ponti L, Hsu K, Damy T, Villacorta E, Verheyen N, Keohane D, Wang R, Ines M, Kumar N, Munteanu C
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
A Qualitative Study of Artificial Intelligence-Based Tools to Raise Suspicion for ATTR Cardiomyopathy
Cheema B, Baylor L, Bhambri R, Ebrahim A, Ahmad
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Clinical red flags associated with transthyretin amyloid cardiomyopathy in patients with unexplained hypertrophic cardiomyopathy: results of the TTRACK study
Damy T, Garcia-Pavia P, Piriou N, Cappelli F, Barriales Villa R, Munteanu C, Bahus C, Keohane D, Mallaina P, Elliott P
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
A final, consolidated overview of 16 years of data from the Transthyretin Amyloidosis Outcomes Survey
Dispenzieri A, Grogan M, Conceicao I, Waddington-Cruz M, Kristen A, Cariou E, Wixner J, Diemberger I, Carlsson M, Amass L, Angeli F, Coehlo T
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Long-term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction
Drachman B, Damy T, Hanna M, Wang R, Angeli F, Garcia-Pavia P
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study
Garcia-Pavia P, Sultan MB, Gundapaneni B, Sekijima Y, Perfetto F, Hanna M, Witteles R
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Survival in a real-world cohort of patients with transthyretin amyloid cardiomyopathy treated with tafamidis: an analysis from the Transthyretin Amyloidosis Outcomes Survey
Garcia-Pavia P, Kristen A, Drachman B, Carlsson M, Amass L, Angeli F, Maurer M
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: cardiac imaging and electrocardiographic findings from the TTRACK study
Garcia-Pavia P, Damy T, Barriales Villa R, Piriou N, Cappelli F, Munteanu C, Bahus C, Keohane D, Mallaina P, Elliott P
ISA 2024
- 国际淀粉样变学会年会 2024
| 罕见病 | 转甲状腺素蛋白淀粉样变性
